Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-4 of 4 for Hypoparathyroidism

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Clinical Study Investigating the Safety, Tolerability, PK and PD of PCO371 in Patients With Hypoparathyroidism

    Rochester, MN

  2. A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism

    Rochester, MN

  3. A Study to Assess an Intact Parathyroid Hormone Assay Under Development by Ortho Clinical Diagnostics

    Rochester, MN

  4. A Registry for Patients With Chronic Hypoparathyroidism

    Rochester, MN

.

Mayo Clinic Footer